Atlas Trials

Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors

Clinical trial NCT03792724 · UNKNOWN

Trial details

NCT number
NCT03792724
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neoplasms
Start date
2019-01-30
Primary completion
2023-01-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.